Growth Metrics

Repligen (RGEN) EBITDA Margin (2016 - 2025)

Repligen (RGEN) has disclosed EBITDA Margin for 16 consecutive years, with 7.51% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 3841.0% to 7.51% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13.4% through Dec 2025, up 1974.0% year-over-year, with the annual reading at 13.4% for FY2025, 1974.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 7.51% at Repligen, up from 6.63% in the prior quarter.
  • The five-year high for EBITDA Margin was 105.92% in Q1 2023, with the low at 30.9% in Q4 2024.
  • Average EBITDA Margin over 5 years is 14.85%, with a median of 9.84% recorded in 2022.
  • The sharpest move saw EBITDA Margin surged 8544bps in 2023, then crashed -10712bps in 2024.
  • Over 5 years, EBITDA Margin stood at 11.87% in 2021, then surged by 214bps to 37.26% in 2022, then plummeted by -118bps to 6.54% in 2023, then plummeted by -373bps to 30.9% in 2024, then soared by 124bps to 7.51% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 7.51%, 6.63%, and 33.44% for Q4 2025, Q3 2025, and Q2 2025 respectively.